The Continuing Debate Over Follow-On Biologics by Deborah M. Shelton, Associate with the law firm of Arent Fox PLLC, Washington, D.C.

Proposed Canadian Amendments Will Affect Innovative Drug Companies
by Conor McCourt, Partner in the Intellectual Property Group in the Toronto office of Torys LLP

Trade Secret Theft by Employees
by Tanya J. Dobash, Vice President & Senior Counsel, Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY

 

New Case Raises Doubts on FDA's Authority to Obtain Restitution and Disgorgement
by Jeffrey N. Wasserstein, Principal with the law firm of Hyman, Phelps & McNamara, P.C., Washington, D.C.
and
Christine P. Bump, Associate with the law firm of Hyman, Phelps & McNamara, P.C., Washington, D.C.

New Sheriffs on the Block: Growing Number of State Laws Target Drug Marketing and Promotion
by Sandra Cohen Kalter, Counsel in the FDA/Healthcare Practice at King & Spalding LLP
and
Kelly N. Reeves, Senior Associate in the FDA/Healthcare Practice at King & Spalding LLP

Further Protecting the Food Supply—FDA's Final Rule on Recordkeeping Requirements
by Cassandra A. Soltis, Attorney with the law firm of Hyman, Phelps & McNamara, P.C., Washington, D.C.

Expert Witnesses in Product Liability Litigation: Boon or Bust?
by Thomas N. Tiedt, Ph.D., Director, Med-Tox Group, Bradenton, FL

Canadian Internet Pharmacies—Recent Developments
by Brian Daley, Partner in the law firm of Ogilvy Renault, Montreal, Canada

 

History Corner
Popular Images of Drug Adulteration
by Suzanne White Junod, Ph.D., Historian with the Food and Drug Administration, Rockville, MD

Enforcement Corner
The Government's Focus Now Includes a Company's Culture
by Steven M. Kowal, Chair of the White Collar Criminal Defense Group at the law firm of Bell, Boyd & Lloyd LLC, Chicago, IL

Global Corner
Generic Biologics
by Matthew R. Weinberg, Chief Executive Officer, THE WEINBERG GROUP, Washington, D.C.

Associates' Corner
Patent Prosecution Strategies in Light of Orange Book Listing Requirements
by Mary C. Till, Associate with the law firm of Foley Lardner, LLP, Washington, D.C.

Note: All author affiliations are current as of the date of publication of the issue.